A team at the Lawrence Livermore National Laboratory has achieved fusion ignition, producing a net energy gain from a fusion reaction for the first time ever. The feat was hailed as a “moment of history” by physicists and another major breakthrough in the quest for near-limitless clean energy.
The discovery of a new compound that can kill a drug-resistant bacterium that kills thousands worldwide every year could prove to be a turning point in the fight against antibiotic resistance.
Researchers at the Massachusetts Institute of Technology exposed CO2 to catalysts and then electrolysis that turns the gas into a powder called sodium formate, which can be safely stored for decades. The breakthrough follows an almost century-long effort to turn CO2 into a cheap, clean fuel. Researchers have previously turned CO2 into fuels that required too much energy to make or were difficult to store long-term.
New research from Maryland-based Sunstone Therapies found that psilocybin-assisted therapy for cancer patients induced a clinically meaningful improvement in depression symptoms, with 80% of participants demonstrating a sustained response and 50% showing full remission of depression symptoms at week one, which was sustained for eight weeks.
A drug that targets the deadliest form of breast cancer was administered to 16 women in three separate doses in a trial conducted at the Cleveland Clinic with funding from the Pentagon. The trial found that the drug elicits no side effects and triggered an immune response in 75% of patients.
The reactor, dubbed JT-60SA, represents the latest testbed for a potentially transformative source of renewable energy harvested from atoms fusing together under immense pressure and incredibly high temperatures — without risking a nuclear meltdown.
In the first trial, at the Peter MacCallum Cancer Center in Australia, CRC patients receiving just divarasib had a 35.9% positive response rate, which was considered extremely promising.
After only two doses, nearly eight out of ten participants in a phase 2 trial by Toronto-based pharmaceutical company Cybin experienced remission from major depressive disorder at six weeks. The company has a planned phase 3 study slated to commence by the end of Q1 2024.
SAF is designed to cut aviation carbon emissions by using sources that rely much less on fossil fuels: include maize, seed oils, algae, animal fats, oils, greases, farm residues, and more. According to Gulfstream, SAF has the potential to reduce net carbon emissions by 70%.
Northwestern University’s Prison Education Program has now welcomed its inaugural graduating class of incarcerated students. Around 100 students are enrolled in the Northwestern program across Stateville Correctional Center for men and the Logan Correctional Center for women.
